drugset / Trial / NCT00963846
Huperzine for Cognitive and Functional Impairment in Schizophrenia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Huperzine is a natural plant product with procognitive properties in patients with Alzheimer's disease. Cognitive difficulties hamper functioning in schizophrenia as well. The present study will investigate whether huperzine improves cognition and functioning in patients with schizophrenia.
Timeline
- Start
- 2010-03
- Primary completion
- 2012-12
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Huperzine | Unknown | 0.2 mg | — |
| Subject | Huperzine | Unknown | 0.4 mg | — |
| Subject | Huperzine | Unknown | 0.8 mg | — |